| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 6.20e-07 | 193 | 18 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 6.86e-07 | 197 | 18 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 6.56e-06 | 140 | 18 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | gated channel activity | 9.10e-06 | 334 | 18 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 4.20e-05 | 459 | 18 | 5 | GO:0005216 | |
| GeneOntologyMolecularFunction | ATP-dependent diacylglycerol kinase activity | 4.20e-05 | 11 | 18 | 2 | GO:0004143 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 4.74e-05 | 793 | 18 | 6 | GO:0015075 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 5.95e-05 | 13 | 18 | 2 | GO:0042166 | |
| GeneOntologyMolecularFunction | channel activity | 7.95e-05 | 525 | 18 | 5 | GO:0015267 | |
| GeneOntologyMolecularFunction | chloride channel regulator activity | 8.00e-05 | 15 | 18 | 2 | GO:0017081 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 8.02e-05 | 526 | 18 | 5 | GO:0022803 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 9.14e-05 | 16 | 18 | 2 | GO:0008179 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 9.99e-05 | 102 | 18 | 3 | GO:0001540 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 1.04e-04 | 17 | 18 | 2 | GO:0022848 | |
| GeneOntologyMolecularFunction | toxic substance binding | 1.16e-04 | 18 | 18 | 2 | GO:0015643 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 1.92e-04 | 23 | 18 | 2 | GO:0015464 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.00e-04 | 129 | 18 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.16e-04 | 343 | 18 | 4 | GO:0005261 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 2.39e-04 | 664 | 18 | 5 | GO:0008324 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.18e-04 | 151 | 18 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 4.22e-04 | 1180 | 18 | 6 | GO:0022857 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 4.41e-04 | 758 | 18 | 5 | GO:0015318 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 6.16e-04 | 41 | 18 | 2 | GO:0001727 | |
| GeneOntologyMolecularFunction | transporter activity | 6.76e-04 | 1289 | 18 | 6 | GO:0005215 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 6.78e-04 | 43 | 18 | 2 | GO:0005231 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 6.85e-04 | 465 | 18 | 4 | GO:0046873 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.19e-03 | 57 | 18 | 2 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.32e-03 | 60 | 18 | 2 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.54e-03 | 65 | 18 | 2 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.54e-03 | 65 | 18 | 2 | GO:0022824 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 2.05e-03 | 75 | 18 | 2 | GO:0098960 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 2.07e-03 | 627 | 18 | 4 | GO:0022890 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.16e-03 | 77 | 18 | 2 | GO:0005230 | |
| GeneOntologyMolecularFunction | amide binding | 2.30e-03 | 299 | 18 | 3 | GO:0033218 | |
| GeneOntologyMolecularFunction | peptide binding | 2.73e-03 | 318 | 18 | 3 | GO:0042277 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 3.13e-03 | 93 | 18 | 2 | GO:0097110 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 3.61e-03 | 100 | 18 | 2 | GO:0030594 | |
| GeneOntologyMolecularFunction | ATPase binding | 4.19e-03 | 108 | 18 | 2 | GO:0051117 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 9.19e-03 | 162 | 18 | 2 | GO:0099106 | |
| GeneOntologyMolecularFunction | channel regulator activity | 1.05e-02 | 174 | 18 | 2 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 1.09e-02 | 177 | 18 | 2 | GO:0141108 | |
| GeneOntologyBiologicalProcess | presynaptic modulation of chemical synaptic transmission | 3.01e-07 | 67 | 18 | 4 | GO:0099171 | |
| GeneOntologyBiologicalProcess | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | 7.19e-07 | 2 | 18 | 2 | GO:0001988 | |
| GeneOntologyBiologicalProcess | baroreceptor response to decreased systemic arterial blood pressure | 2.16e-06 | 3 | 18 | 2 | GO:0001982 | |
| GeneOntologyBiologicalProcess | generation of ovulation cycle rhythm | 4.31e-06 | 4 | 18 | 2 | GO:0060112 | |
| GeneOntologyBiologicalProcess | sensory processing | 7.18e-06 | 5 | 18 | 2 | GO:0050893 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback | 1.08e-05 | 6 | 18 | 2 | GO:0001978 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by baroreceptor feedback | 2.01e-05 | 8 | 18 | 2 | GO:0003025 | |
| GeneOntologyBiologicalProcess | positive regulation of CoA-transferase activity | 2.58e-05 | 9 | 18 | 2 | GO:1905920 | |
| GeneOntologyBiologicalProcess | regulation of CoA-transferase activity | 3.94e-05 | 11 | 18 | 2 | GO:1905918 | |
| GeneOntologyBiologicalProcess | behavioral response to nicotine | 3.94e-05 | 11 | 18 | 2 | GO:0035095 | |
| GeneOntologyBiologicalProcess | lipid phosphorylation | 3.94e-05 | 11 | 18 | 2 | GO:0046834 | |
| GeneOntologyBiologicalProcess | regulation of synapse structural plasticity | 4.72e-05 | 12 | 18 | 2 | GO:0051823 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, dopaminergic | 5.58e-05 | 13 | 18 | 2 | GO:0032225 | |
| GeneOntologyBiologicalProcess | dendrite arborization | 7.50e-05 | 15 | 18 | 2 | GO:0140059 | |
| GeneOntologyBiologicalProcess | behavioral response to ethanol | 9.71e-05 | 17 | 18 | 2 | GO:0048149 | |
| GeneOntologyBiologicalProcess | regulation of amyloid fibril formation | 1.22e-04 | 19 | 18 | 2 | GO:1905906 | |
| GeneOntologyBiologicalProcess | regulation of response to drug | 1.50e-04 | 21 | 18 | 2 | GO:2001023 | |
| GeneOntologyBiologicalProcess | positive regulation of amyloid-beta formation | 1.80e-04 | 23 | 18 | 2 | GO:1902004 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 1.86e-04 | 130 | 18 | 3 | GO:0060079 | |
| GeneOntologyBiologicalProcess | nervous system process involved in regulation of systemic arterial blood pressure | 1.96e-04 | 24 | 18 | 2 | GO:0001976 | |
| GeneOntologyBiologicalProcess | import into cell | 2.12e-04 | 1074 | 18 | 6 | GO:0098657 | |
| GeneOntologyBiologicalProcess | regulation of norepinephrine secretion | 2.31e-04 | 26 | 18 | 2 | GO:0014061 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 2.60e-04 | 1115 | 18 | 6 | GO:0034220 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 2.68e-04 | 147 | 18 | 3 | GO:0099565 | |
| GeneOntologyBiologicalProcess | norepinephrine secretion | 2.68e-04 | 28 | 18 | 2 | GO:0048243 | |
| GeneOntologyBiologicalProcess | positive regulation of systemic arterial blood pressure | 2.68e-04 | 28 | 18 | 2 | GO:0003084 | |
| GeneOntologyBiologicalProcess | diacylglycerol metabolic process | 2.68e-04 | 28 | 18 | 2 | GO:0046339 | |
| GeneOntologyBiologicalProcess | positive regulation of amyloid precursor protein catabolic process | 2.88e-04 | 29 | 18 | 2 | GO:1902993 | |
| GeneOntologyBiologicalProcess | positive regulation of long-term synaptic potentiation | 3.97e-04 | 34 | 18 | 2 | GO:1900273 | |
| GeneOntologyBiologicalProcess | positive regulation of heart rate | 4.21e-04 | 35 | 18 | 2 | GO:0010460 | |
| GeneOntologyBiologicalProcess | synaptic transmission, dopaminergic | 4.21e-04 | 35 | 18 | 2 | GO:0001963 | |
| GeneOntologyBiologicalProcess | phosphatidic acid biosynthetic process | 4.45e-04 | 36 | 18 | 2 | GO:0006654 | |
| GeneOntologyBiologicalProcess | positive regulation of amide metabolic process | 4.70e-04 | 37 | 18 | 2 | GO:0034250 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 4.84e-04 | 180 | 18 | 3 | GO:0060078 | |
| GeneOntologyBiologicalProcess | neuron projection arborization | 4.96e-04 | 38 | 18 | 2 | GO:0140058 | |
| GeneOntologyBiologicalProcess | norepinephrine transport | 4.96e-04 | 38 | 18 | 2 | GO:0015874 | |
| GeneOntologyBiologicalProcess | flagellated sperm motility | 5.33e-04 | 186 | 18 | 3 | GO:0030317 | |
| GeneOntologyBiologicalProcess | phosphatidic acid metabolic process | 5.78e-04 | 41 | 18 | 2 | GO:0046473 | |
| GeneOntologyBiologicalProcess | sperm motility | 5.93e-04 | 193 | 18 | 3 | GO:0097722 | |
| GeneOntologyBiologicalProcess | positive regulation of excitatory postsynaptic potential | 6.36e-04 | 43 | 18 | 2 | GO:2000463 | |
| GeneOntologyBiologicalProcess | synaptic transmission, cholinergic | 6.66e-04 | 44 | 18 | 2 | GO:0007271 | |
| GeneOntologyBiologicalProcess | amyloid fibril formation | 6.96e-04 | 45 | 18 | 2 | GO:1990000 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 7.58e-04 | 210 | 18 | 3 | GO:0060294 | |
| GeneOntologyBiologicalProcess | learning | 7.79e-04 | 212 | 18 | 3 | GO:0007612 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | 7.99e-04 | 1374 | 18 | 6 | GO:0006811 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 8.12e-04 | 215 | 18 | 3 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 8.12e-04 | 215 | 18 | 3 | GO:0001539 | |
| GeneOntologyBiologicalProcess | positive regulation of heart contraction | 8.26e-04 | 49 | 18 | 2 | GO:0045823 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 8.52e-04 | 509 | 18 | 4 | GO:0006816 | |
| GeneOntologyBiologicalProcess | regulation of amyloid-beta formation | 8.60e-04 | 50 | 18 | 2 | GO:1902003 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 beta production | 8.60e-04 | 50 | 18 | 2 | GO:0032691 | |
| GeneOntologyBiologicalProcess | acetylcholine receptor signaling pathway | 8.94e-04 | 51 | 18 | 2 | GO:0095500 | |
| GeneOntologyBiologicalProcess | response to cold | 9.29e-04 | 52 | 18 | 2 | GO:0009409 | |
| GeneOntologyBiologicalProcess | positive regulation of blood circulation | 9.65e-04 | 53 | 18 | 2 | GO:1903524 | |
| GeneOntologyBiologicalProcess | cellular response to acetylcholine | 9.65e-04 | 53 | 18 | 2 | GO:1905145 | |
| GeneOntologyBiologicalProcess | response to acetylcholine | 1.08e-03 | 56 | 18 | 2 | GO:1905144 | |
| GeneOntologyBiologicalProcess | response to nicotine | 1.16e-03 | 58 | 18 | 2 | GO:0035094 | |
| GeneOntologyBiologicalProcess | response to food | 1.16e-03 | 58 | 18 | 2 | GO:0032094 | |
| GeneOntologyBiologicalProcess | regulation of amyloid precursor protein catabolic process | 1.19e-03 | 59 | 18 | 2 | GO:1902991 | |
| GeneOntologyBiologicalProcess | positive regulation of blood pressure | 1.19e-03 | 59 | 18 | 2 | GO:0045777 | |
| GeneOntologyBiologicalProcess | amyloid-beta formation | 1.19e-03 | 59 | 18 | 2 | GO:0034205 | |
| GeneOntologyBiologicalProcess | response to amyloid-beta | 1.28e-03 | 61 | 18 | 2 | GO:1904645 | |
| GeneOntologyBiologicalProcess | regulation of Ras protein signal transduction | 1.28e-03 | 61 | 18 | 2 | GO:0046578 | |
| GeneOntologyBiologicalProcess | metal ion transport | 1.34e-03 | 1000 | 18 | 5 | GO:0030001 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.36e-03 | 63 | 18 | 2 | GO:0019228 | |
| GeneOntologyBiologicalProcess | cilium movement | 1.42e-03 | 261 | 18 | 3 | GO:0003341 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 1.44e-03 | 1017 | 18 | 5 | GO:0098660 | |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 1.45e-03 | 65 | 18 | 2 | GO:0098815 | |
| GeneOntologyBiologicalProcess | regulation of catecholamine secretion | 1.54e-03 | 67 | 18 | 2 | GO:0050433 | |
| GeneOntologyBiologicalProcess | regulation of long-term synaptic potentiation | 1.54e-03 | 67 | 18 | 2 | GO:1900271 | |
| GeneOntologyBiologicalProcess | ovulation cycle process | 1.58e-03 | 68 | 18 | 2 | GO:0022602 | |
| GeneOntologyBiologicalProcess | amyloid-beta metabolic process | 1.63e-03 | 69 | 18 | 2 | GO:0050435 | |
| GeneOntologyBiologicalProcess | postsynaptic signal transduction | 1.63e-03 | 69 | 18 | 2 | GO:0098926 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 1.77e-03 | 72 | 18 | 2 | GO:0032692 | |
| GeneOntologyBiologicalProcess | amyloid precursor protein catabolic process | 1.82e-03 | 73 | 18 | 2 | GO:0042987 | |
| GeneOntologyBiologicalProcess | regulation of synaptic plasticity | 1.98e-03 | 293 | 18 | 3 | GO:0048167 | |
| GeneOntologyBiologicalProcess | regulation of antigen receptor-mediated signaling pathway | 2.02e-03 | 77 | 18 | 2 | GO:0050854 | |
| GeneOntologyBiologicalProcess | catecholamine secretion | 2.13e-03 | 79 | 18 | 2 | GO:0050432 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-6 production | 2.18e-03 | 80 | 18 | 2 | GO:0032715 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 2.26e-03 | 663 | 18 | 4 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 2.27e-03 | 664 | 18 | 4 | GO:0099177 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 2.38e-03 | 313 | 18 | 3 | GO:0099173 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | 2.55e-03 | 1157 | 18 | 5 | GO:0006812 | |
| GeneOntologyBiologicalProcess | regulation of amide metabolic process | 2.63e-03 | 88 | 18 | 2 | GO:0034248 | |
| GeneOntologyBiologicalProcess | negative regulation of tumor necrosis factor production | 2.81e-03 | 91 | 18 | 2 | GO:0032720 | |
| GeneOntologyBiologicalProcess | negative regulation of tumor necrosis factor superfamily cytokine production | 2.94e-03 | 93 | 18 | 2 | GO:1903556 | |
| GeneOntologyBiologicalProcess | B cell activation | 3.04e-03 | 341 | 18 | 3 | GO:0042113 | |
| GeneOntologyBiologicalProcess | negative regulation of ERK1 and ERK2 cascade | 3.06e-03 | 95 | 18 | 2 | GO:0070373 | |
| GeneOntologyBiologicalProcess | ovulation cycle | 3.06e-03 | 95 | 18 | 2 | GO:0042698 | |
| GeneOntologyBiologicalProcess | catecholamine transport | 3.12e-03 | 96 | 18 | 2 | GO:0051937 | |
| GeneOntologyBiologicalProcess | amyloid precursor protein metabolic process | 3.45e-03 | 101 | 18 | 2 | GO:0042982 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation | 3.45e-03 | 101 | 18 | 2 | GO:0033138 | |
| GeneOntologyBiologicalProcess | learning or memory | 3.91e-03 | 373 | 18 | 3 | GO:0007611 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 4.22e-03 | 112 | 18 | 2 | GO:0019226 | |
| GeneOntologyBiologicalProcess | dendritic spine organization | 4.45e-03 | 115 | 18 | 2 | GO:0097061 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 4.50e-03 | 392 | 18 | 3 | GO:0070588 | |
| GeneOntologyBiologicalProcess | monoamine transport | 4.52e-03 | 116 | 18 | 2 | GO:0015844 | |
| GeneOntologyBiologicalProcess | endocytosis | 5.01e-03 | 827 | 18 | 4 | GO:0006897 | |
| GeneOntologyBiologicalProcess | cell activation | 5.07e-03 | 1356 | 18 | 5 | GO:0001775 | |
| GeneOntologyCellularComponent | spine apparatus membrane | 1.87e-06 | 3 | 17 | 2 | GO:0098897 | |
| GeneOntologyCellularComponent | spine apparatus | 2.23e-05 | 9 | 17 | 2 | GO:0097444 | |
| GeneOntologyCellularComponent | asymmetric synapse | 2.99e-05 | 477 | 17 | 5 | GO:0032279 | |
| GeneOntologyCellularComponent | dendritic spine | 3.70e-05 | 242 | 17 | 4 | GO:0043197 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 3.85e-05 | 503 | 17 | 5 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron spine | 4.01e-05 | 247 | 17 | 4 | GO:0044309 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 4.64e-05 | 523 | 17 | 5 | GO:0098984 | |
| GeneOntologyCellularComponent | main axon | 4.86e-05 | 89 | 17 | 3 | GO:0044304 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 9.45e-05 | 18 | 17 | 2 | GO:0005892 | |
| GeneOntologyCellularComponent | postsynapse | 1.02e-04 | 1018 | 17 | 6 | GO:0098794 | |
| GeneOntologyCellularComponent | glycinergic synapse | 1.17e-04 | 20 | 17 | 2 | GO:0098690 | |
| GeneOntologyCellularComponent | axolemma | 1.30e-04 | 21 | 17 | 2 | GO:0030673 | |
| GeneOntologyCellularComponent | cholinergic synapse | 1.42e-04 | 22 | 17 | 2 | GO:0098981 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.08e-04 | 378 | 17 | 4 | GO:0034702 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 2.52e-04 | 155 | 17 | 3 | GO:0098685 | |
| GeneOntologyCellularComponent | dendrite | 4.72e-04 | 858 | 17 | 5 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 4.77e-04 | 860 | 17 | 5 | GO:0097447 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 5.39e-04 | 201 | 17 | 3 | GO:0099634 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 7.11e-04 | 523 | 17 | 4 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 8.59e-04 | 550 | 17 | 4 | GO:1990351 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.36e-03 | 277 | 17 | 3 | GO:0042734 | |
| GeneOntologyCellularComponent | dendritic shaft | 1.62e-03 | 74 | 17 | 2 | GO:0043198 | |
| GeneOntologyCellularComponent | neuron projection membrane | 1.99e-03 | 82 | 17 | 2 | GO:0032589 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 2.37e-03 | 1228 | 17 | 5 | GO:0036477 | |
| GeneOntologyCellularComponent | neuronal cell body | 3.97e-03 | 835 | 17 | 4 | GO:0043025 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 4.01e-03 | 405 | 17 | 3 | GO:0045211 | |
| GeneOntologyCellularComponent | distal axon | 4.90e-03 | 435 | 17 | 3 | GO:0150034 | |
| GeneOntologyCellularComponent | presynapse | 4.90e-03 | 886 | 17 | 4 | GO:0098793 | |
| GeneOntologyCellularComponent | axon | 5.00e-03 | 891 | 17 | 4 | GO:0030424 | |
| GeneOntologyCellularComponent | postsynaptic density | 5.42e-03 | 451 | 17 | 3 | GO:0014069 | |
| GeneOntologyCellularComponent | cell body | 5.80e-03 | 929 | 17 | 4 | GO:0044297 | |
| GeneOntologyCellularComponent | plasma membrane raft | 6.23e-03 | 147 | 17 | 2 | GO:0044853 | |
| GeneOntologyCellularComponent | apical plasma membrane | 6.70e-03 | 487 | 17 | 3 | GO:0016324 | |
| GeneOntologyCellularComponent | cell leading edge | 7.20e-03 | 500 | 17 | 3 | GO:0031252 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.10e-02 | 583 | 17 | 3 | GO:0097060 | |
| GeneOntologyCellularComponent | apical part of cell | 1.14e-02 | 592 | 17 | 3 | GO:0045177 | |
| GeneOntologyCellularComponent | leading edge membrane | 1.24e-02 | 210 | 17 | 2 | GO:0031256 | |
| GeneOntologyCellularComponent | cation channel complex | 1.53e-02 | 235 | 17 | 2 | GO:0034703 | |
| GeneOntologyCellularComponent | growth cone | 1.66e-02 | 245 | 17 | 2 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 1.76e-02 | 253 | 17 | 2 | GO:0030427 | |
| MousePheno | airway basal cell hyperplasia | 7.98e-07 | 2 | 13 | 2 | MP:0011115 | |
| MousePheno | abnormal airway basal cell differentiation | 7.98e-07 | 2 | 13 | 2 | MP:0011114 | |
| MousePheno | abnormal airway basal cell morphology | 7.98e-07 | 2 | 13 | 2 | MP:0011113 | |
| MousePheno | abnormal nicotine-mediated receptor currents | 4.79e-06 | 4 | 13 | 2 | MP:0009475 | |
| MousePheno | failure of neuromuscular synapse presynaptic differentiation | 1.20e-05 | 6 | 13 | 2 | MP:0001054 | |
| MousePheno | abnormal olfactory system physiology | 1.88e-05 | 58 | 13 | 3 | MP:0001983 | |
| MousePheno | abnormal GABAergic neuron physiology | 2.23e-05 | 8 | 13 | 2 | MP:0011987 | |
| MousePheno | impaired spatial working memory | 5.24e-05 | 12 | 13 | 2 | MP:0014370 | |
| MousePheno | decreased erythroblast number | 5.24e-05 | 12 | 13 | 2 | MP:0011179 | |
| MousePheno | abnormal GABA-mediated receptor currents | 1.21e-04 | 18 | 13 | 2 | MP:0004008 | |
| MousePheno | decreased CNS synapse formation | 1.82e-04 | 22 | 13 | 2 | MP:0004998 | |
| MousePheno | taste/olfaction phenotype | 1.87e-04 | 125 | 13 | 3 | MP:0005394 | |
| MousePheno | abnormal GABAergic neuron morphology | 2.37e-04 | 25 | 13 | 2 | MP:0003245 | |
| MousePheno | impaired olfaction | 3.20e-04 | 29 | 13 | 2 | MP:0008544 | |
| MousePheno | abnormal cerebral cortex pyramidal cell morphology | 3.90e-04 | 32 | 13 | 2 | MP:0009969 | |
| MousePheno | abnormal somatosensory cortex morphology | 4.15e-04 | 33 | 13 | 2 | MP:0000859 | |
| MousePheno | abnormal erythroblast number | 4.67e-04 | 35 | 13 | 2 | MP:0011177 | |
| MousePheno | abnormal CNS synapse formation | 4.67e-04 | 35 | 13 | 2 | MP:0004996 | |
| MousePheno | abnormal brain interneuron morphology | 5.22e-04 | 37 | 13 | 2 | MP:0004101 | |
| MousePheno | abnormal parietal lobe morphology | 5.22e-04 | 37 | 13 | 2 | MP:0000794 | |
| MousePheno | prolonged estrous cycle | 5.80e-04 | 39 | 13 | 2 | MP:0009006 | |
| MousePheno | abnormal erythroblast morphology | 7.73e-04 | 45 | 13 | 2 | MP:0011176 | |
| MousePheno | abnormal bone structure | 8.49e-04 | 1379 | 13 | 6 | MP:0003795 | |
| MousePheno | abnormal olfaction | 9.54e-04 | 50 | 13 | 2 | MP:0001984 | |
| MousePheno | abnormal eating behavior | 1.81e-03 | 604 | 13 | 4 | MP:0001431 | |
| MousePheno | abnormal proerythroblast morphology | 2.08e-03 | 74 | 13 | 2 | MP:0002416 | |
| MousePheno | reduced female fertility | 2.30e-03 | 296 | 13 | 3 | MP:0001923 | |
| MousePheno | abnormal consumption behavior | 3.02e-03 | 695 | 13 | 4 | MP:0002069 | |
| MousePheno | abnormal spatial working memory | 3.33e-03 | 94 | 13 | 2 | MP:0008428 | |
| MousePheno | abnormal neuromuscular synapse morphology | 3.40e-03 | 95 | 13 | 2 | MP:0001053 | |
| Domain | DAGK_acc | 3.93e-05 | 10 | 18 | 2 | PF00609 | |
| Domain | DAGKa | 3.93e-05 | 10 | 18 | 2 | SM00045 | |
| Domain | Diacylglycerol_kin_accessory | 3.93e-05 | 10 | 18 | 2 | IPR000756 | |
| Domain | DAGKc | 7.93e-05 | 14 | 18 | 2 | SM00046 | |
| Domain | DAGK | 9.14e-05 | 15 | 18 | 2 | PS50146 | |
| Domain | Diacylglycerol_kinase_cat_dom | 9.14e-05 | 15 | 18 | 2 | IPR001206 | |
| Domain | DAGK_cat | 9.14e-05 | 15 | 18 | 2 | PF00781 | |
| Domain | NAD/diacylglycerol_kinase | 1.18e-04 | 17 | 18 | 2 | IPR016064 | |
| Domain | - | 2.19e-04 | 23 | 18 | 2 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 2.19e-04 | 23 | 18 | 2 | IPR027361 | |
| Domain | Neurotransmitter_ion_chnl_CS | 8.47e-04 | 45 | 18 | 2 | IPR018000 | |
| Domain | Neur_chan_memb | 8.85e-04 | 46 | 18 | 2 | PF02932 | |
| Domain | Neur_chan_LBD | 9.24e-04 | 47 | 18 | 2 | PF02931 | |
| Domain | Neur_channel | 9.24e-04 | 47 | 18 | 2 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 9.24e-04 | 47 | 18 | 2 | IPR006202 | |
| Domain | Neurotrans-gated_channel_TM | 9.24e-04 | 47 | 18 | 2 | IPR006029 | |
| Domain | NEUROTR_ION_CHANNEL | 9.24e-04 | 47 | 18 | 2 | PS00236 | |
| Domain | - | 9.24e-04 | 47 | 18 | 2 | 2.70.170.10 | |
| Domain | C1_1 | 1.36e-03 | 57 | 18 | 2 | PF00130 | |
| Domain | ZF_DAG_PE_2 | 1.71e-03 | 64 | 18 | 2 | PS50081 | |
| Domain | ZF_DAG_PE_1 | 1.71e-03 | 64 | 18 | 2 | PS00479 | |
| Domain | C1 | 1.76e-03 | 65 | 18 | 2 | SM00109 | |
| Domain | PE/DAG-bd | 1.81e-03 | 66 | 18 | 2 | IPR002219 | |
| Domain | Ion_trans_dom | 5.30e-03 | 114 | 18 | 2 | IPR005821 | |
| Domain | Ion_trans | 5.30e-03 | 114 | 18 | 2 | PF00520 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 5.15e-05 | 12 | 13 | 2 | MM15312 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 8.19e-05 | 15 | 13 | 2 | MM14704 | |
| Pathway | WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME | 1.96e-04 | 23 | 13 | 2 | M39883 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 2.33e-04 | 25 | 13 | 2 | MM14511 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 2.72e-04 | 27 | 13 | 2 | M12123 | |
| Pathway | KEGG_GLYCEROLIPID_METABOLISM | 9.01e-04 | 49 | 13 | 2 | M15902 | |
| Pathway | WP_15Q11Q13_COPY_NUMBER_VARIATION | 1.30e-03 | 59 | 13 | 2 | M48104 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 2.15e-03 | 76 | 13 | 2 | M9052 | |
| Pathway | KEGG_GLYCEROPHOSPHOLIPID_METABOLISM | 2.21e-03 | 77 | 13 | 2 | M9131 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 21437621 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 38822526 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 26937017 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 38070724 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 22314319 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 19626424 | ||
| Pubmed | α7 nicotinic receptors play a role in regulation of cardiac hemodynamics. | 2.83e-07 | 2 | 19 | 2 | 37017608 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 17012698 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 38253622 | ||
| Pubmed | Impaired hippocampal theta oscillations in the mice null alpha7 nicotinic acetylcholine receptors. | 2.83e-07 | 2 | 19 | 2 | 23795917 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 20595621 | ||
| Pubmed | Antagonism of Cerebral High Mobility Group Box 1 Ameliorates Dendritic Cell Dysfunction in Sepsis. | 2.83e-07 | 2 | 19 | 2 | 34512319 | |
| Pubmed | Cholinergic Pathway Suppresses Pulmonary Innate Immunity Facilitating Pneumonia After Stroke. | 2.83e-07 | 2 | 19 | 2 | 26451017 | |
| Pubmed | Cholinergic receptors modulate immune complex-induced inflammation in vitro and in vivo. | 2.83e-07 | 2 | 19 | 2 | 23851693 | |
| Pubmed | Nicotine stimulates nerve growth factor in lung fibroblasts through an NFκB-dependent mechanism. | 2.83e-07 | 2 | 19 | 2 | 25296021 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 36603528 | ||
| Pubmed | Visual acuity is reduced in alpha 7 nicotinic receptor knockout mice. | 2.83e-07 | 2 | 19 | 2 | 22281823 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 20592195 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 34514543 | ||
| Pubmed | Activation of α7nAChR Promotes Diabetic Wound Healing by Suppressing AGE-Induced TNF-α Production. | 2.83e-07 | 2 | 19 | 2 | 26650489 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 34453977 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 33718373 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 11854451 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 24757672 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 26965141 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 25993608 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 22848433 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 26999808 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 25895149 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 36064538 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 27676657 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 22183893 | ||
| Pubmed | Delayed procedural learning in α7-nicotinic acetylcholine receptor knockout mice. | 2.83e-07 | 2 | 19 | 2 | 21679297 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 27129924 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 17291692 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 23842742 | ||
| Pubmed | Sensorimotor gating and spatial learning in α7-nicotinic receptor knockout mice. | 2.83e-07 | 2 | 19 | 2 | 23521765 | |
| Pubmed | Central role of alpha7 nicotinic receptor in differentiation of the stratified squamous epithelium. | 2.83e-07 | 2 | 19 | 2 | 12391028 | |
| Pubmed | Abeta(1-42) modulation of Akt phosphorylation via alpha7 nAChR and NMDA receptors. | 2.83e-07 | 2 | 19 | 2 | 17292512 | |
| Pubmed | Functional alpha 7-containing nicotinic receptors of NG2-expressing cells in the hippocampus. | 2.83e-07 | 2 | 19 | 2 | 19170184 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 17462791 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 28258105 | ||
| Pubmed | Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. | 2.83e-07 | 2 | 19 | 2 | 16650968 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 15555774 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 9364063 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 35413868 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 23637989 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 19344760 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 9782083 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 35100606 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 33109433 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 19846875 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 24462939 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 29261717 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 25365546 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 12606407 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 8804729 | ||
| Pubmed | α7 Nicotinic Acetylcholine Receptor Regulates the Function and Viability of L Cells. | 2.83e-07 | 2 | 19 | 2 | 29992246 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 35926661 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 17640819 | ||
| Pubmed | Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice. | 2.83e-07 | 2 | 19 | 2 | 18199426 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 12562921 | ||
| Pubmed | Genetic variations in CHRNA7 or CHRFAM7 and susceptibility to dementia. | 2.83e-07 | 2 | 19 | 2 | 22300029 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 22490926 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 16545784 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 36997969 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 27729414 | ||
| Pubmed | A phenotype for the alpha 7 nicotinic acetylcholine receptor null mutant. | 2.83e-07 | 2 | 19 | 2 | 15364017 | |
| Pubmed | Lung epithelial response to cigarette smoke and modulation by the nicotinic alpha 7 receptor. | 2.83e-07 | 2 | 19 | 2 | 29117258 | |
| Pubmed | Contribution of α7 nicotinic receptor to airway epithelium dysfunction under nicotine exposure. | 2.83e-07 | 2 | 19 | 2 | 23431157 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 23769729 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 18627272 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 29114104 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 15944242 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 32018068 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 23270857 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 18077004 | ||
| Pubmed | CHRFAM7A expression in mice increases resiliency after injury. | 2.83e-07 | 2 | 19 | 2 | 34792616 | |
| Pubmed | An ovarian phenotype of alpha 7 nicotinic receptor knockout mice. | 2.83e-07 | 2 | 19 | 2 | 37432973 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 19462340 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 26206074 | ||
| Pubmed | Nicotine elicits prolonged calcium signaling along ventral hippocampal axons. | 2.83e-07 | 2 | 19 | 2 | 24349346 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 33995108 | ||
| Pubmed | Tolerance to nicotine in mice lacking alpha7 nicotinic receptors. | 2.83e-07 | 2 | 19 | 2 | 15723228 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 28384302 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 32552811 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 16923147 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 11790782 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 21143250 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 28551099 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 11424985 | ||
| Pubmed | Cholinergic modulation of appetite-related synapses in mouse lateral hypothalamic slice. | 2.83e-07 | 2 | 19 | 2 | 16319313 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 10942027 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 24836856 | ||
| Pubmed | β-Cell mass restoration by α7 nicotinic acetylcholine receptor activation. | 2.83e-07 | 2 | 19 | 2 | 30397183 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 32413437 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 31904546 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 16785311 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 15948184 | ||
| Pubmed | Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. | 2.83e-07 | 2 | 19 | 2 | 19116908 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q13 | 9.47e-06 | 100 | 19 | 3 | chr15q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p22 | 1.46e-03 | 137 | 19 | 2 | chr1p22 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 2.88e-05 | 10 | 15 | 2 | 1178 | |
| Coexpression | HEVNER_SUBPLATE_PROJECTION_NEURONS | 3.27e-05 | 12 | 19 | 2 | MM416 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-06 | 185 | 19 | 4 | bea69058afa5aa927fe15c1f8d46460562ec4dd4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-06 | 185 | 19 | 4 | dbbd348714cd16a4948a04648e914b1e71e2a8ef | |
| ToppCell | Club_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.19e-05 | 147 | 19 | 3 | 5a824c89e4d045af465d7333275f8191fb29b041 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.17e-05 | 173 | 19 | 3 | af85fb9f6e26a044ca4d23e5872039b1a7b73b1b | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 5.73e-05 | 179 | 19 | 3 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.02e-05 | 182 | 19 | 3 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 183 | 19 | 3 | 99bb4ceb92f6467f2359a42ab2cff6df18825a30 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 6.11e-05 | 183 | 19 | 3 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 183 | 19 | 3 | 25c96df8ea0c7bbedbb7699ee84ad6234d19cba8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-05 | 184 | 19 | 3 | 6b0c110d8930df99043c3b99cf4d873985126960 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-05 | 184 | 19 | 3 | 35928fc5f7bbf8c7b09181a2bd27e22dff42ec16 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-05 | 184 | 19 | 3 | f6148e9591e8845cc62668e49fd52755257cdc7e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.31e-05 | 185 | 19 | 3 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.31e-05 | 185 | 19 | 3 | 0ca99fcbd30c454bcdc2aa5265a0e4dba25666ea | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.31e-05 | 185 | 19 | 3 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.31e-05 | 185 | 19 | 3 | 0f722ffcc3e78d5c6b1b79d31d00929801a993f1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.31e-05 | 185 | 19 | 3 | c985a4b184d382a79aaff07f81c0efede2c2d493 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.31e-05 | 185 | 19 | 3 | d0d0e000ebe1fc35a987930ceaf7e3369e0c694c | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 6.62e-05 | 188 | 19 | 3 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 6.73e-05 | 189 | 19 | 3 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 7.05e-05 | 192 | 19 | 3 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | PSB|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.72e-05 | 198 | 19 | 3 | 4e6b0d1abc55d7a0d89bd7ecf0f13dc5bed66626 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Dpy19l1_(Neuron.Gad1Gad2.Cplx3-Dpy19l1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.85e-04 | 77 | 19 | 2 | 4a0a2f1a021790ff598a8655811eac1c367316b3 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Dpy19l1_(Neuron.Gad1Gad2.Cplx3-Dpy19l1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.85e-04 | 77 | 19 | 2 | 459fe29a53b88af77a4ced7b11fa1d0a17fec8e5 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.68e-04 | 109 | 19 | 2 | e8e0f2c5f8c9e45f2b4d173569c94275eedfe432 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-03 | 136 | 19 | 2 | 7cd22169fb71c6caf9feb203ad98be8480a54fba | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.52e-03 | 137 | 19 | 2 | 25b5370b63644351efddb8749ef174beca0581cd | |
| ToppCell | Club_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.54e-03 | 138 | 19 | 2 | 133015953fc660d00339f47b415da5e9872313a2 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-03 | 140 | 19 | 2 | 7ca49bd7ba9381e75c10f888775df17e5d46804d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-03 | 140 | 19 | 2 | 1a31bc33d5723b9bc528cc0047ca5f4c80531c7a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-03 | 143 | 19 | 2 | 605532fc0f32979b306cbb58f8796df7d6b24828 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.66e-03 | 143 | 19 | 2 | 10955b54e4a87d035093a2756291ef1d6a14ab63 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-03 | 143 | 19 | 2 | 5cc59deb5a8af8095c1581e585eaeeecdd938621 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-03 | 143 | 19 | 2 | 360a2ea8b64e3b9084f4c4cb8beb0d44106b9edb | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.80e-03 | 149 | 19 | 2 | a85a051e0d82430160967e72fa04b55f43e84513 | |
| ToppCell | Influenza_Severe-CD4+_T_naive|World / Disease group and Cell class | 1.80e-03 | 149 | 19 | 2 | ce6552063510aa3e0b9d6e5b531eea67410e7056 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.82e-03 | 150 | 19 | 2 | 7a381f5ae94eba5eb60dcbf83416b4eb18c279ea | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-03 | 151 | 19 | 2 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-03 | 151 | 19 | 2 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.87e-03 | 152 | 19 | 2 | 854c841c1fc6300b7e9be9c98cbf9b0ce2678690 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-03 | 154 | 19 | 2 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-03 | 154 | 19 | 2 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.92e-03 | 154 | 19 | 2 | 4e9203c220a44c70cd7979796a0b461991422257 | |
| ToppCell | Influenza_Severe-CD4+_T_naive|Influenza_Severe / Disease group and Cell class | 1.99e-03 | 157 | 19 | 2 | 287bdc4e455cd0160261a93d13538e0def49fcd4 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.01e-03 | 158 | 19 | 2 | 8e48952af0831a1fc71ad422e8216b5a92a75991 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.01e-03 | 158 | 19 | 2 | 55214d674808584e4d48f8c5e3b8c0e206cb9bb8 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.01e-03 | 158 | 19 | 2 | e5b55c15a8c99c8d7fc94949f0d3c22e0c3fee7b | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Club|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.01e-03 | 158 | 19 | 2 | 03281e87780e3bacd089903383c016d03c373bf7 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tregs|Lung / Manually curated celltypes from each tissue | 2.01e-03 | 158 | 19 | 2 | f433bc189f000efa34e8e09ab32b3fa22bcf64c4 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.04e-03 | 159 | 19 | 2 | 7b6370c9567da7d40541c6e243efa704ed7e90ae | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.04e-03 | 159 | 19 | 2 | ecd1daa33549541aee3bf4e139ab6732efc8e74c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.07e-03 | 160 | 19 | 2 | 903727c14e370e5705394240f0ef61fe3e0a4c25 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-03 | 160 | 19 | 2 | 1e210e526ea4d84fc58a798a26c0929bcb69fd89 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-03 | 161 | 19 | 2 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_TNFAIP8L3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.09e-03 | 161 | 19 | 2 | a14773afbe0e64662bfa5fce793cd9d05c24a9b5 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-03 | 161 | 19 | 2 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-03 | 161 | 19 | 2 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | facs-Thymus-Epithelium-3m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-03 | 162 | 19 | 2 | 25323785dd33337bcefd05958a4a1a208a9ceb04 | |
| ToppCell | facs-Thymus-Epithelium-3m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-03 | 162 | 19 | 2 | 3dc39db0d5f6f3d7bcc312a6bce7aaeb914138d1 | |
| ToppCell | facs-Thymus-Epithelium-3m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-03 | 162 | 19 | 2 | 0a7138266054ea5954649c8b61ef93905d56b068 | |
| ToppCell | 15-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class | 2.12e-03 | 162 | 19 | 2 | e190c496ed1e206b86566edfee23c99a99fe90d0 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-03 | 162 | 19 | 2 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-2|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 2.14e-03 | 163 | 19 | 2 | 2dfd11f5803822ba01b92adf4395a3b3adda68f5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_TNFAIP8L3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-03 | 163 | 19 | 2 | 7352c30c253f69f65dcb15f46f9c87719741b55b | |
| ToppCell | P07-Endothelial-lymphatic_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.14e-03 | 163 | 19 | 2 | 5cbab3d03bb1af9391ecad635d6eea1dd42c1337 | |
| ToppCell | P07-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.14e-03 | 163 | 19 | 2 | 322ba94c3ec1e1859c2e2195ecb3f7dab8d190f6 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-03 | 163 | 19 | 2 | 13f76f2979558f5cd27fbfd1659b413b3cac18f5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1_VIP_PCDH20|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-03 | 163 | 19 | 2 | 725927926a07308013cf0c527fb6c54e99189ac0 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-03 | 164 | 19 | 2 | 5e5bd81414ea2d64f73cdef19a0a78c17bec8c18 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-03 | 164 | 19 | 2 | f13b8d9b7f42193f333d9a77571a1dde6bbb48d8 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-03 | 164 | 19 | 2 | 4cfc9f92e49f86d3639e018b35b6a60dc62f494a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-2_VIP_PPAPDC1A|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-03 | 164 | 19 | 2 | e1032c406325873206c588ecdbee587d3e37e0ec | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-03 | 164 | 19 | 2 | ed7e0c8ccad7d19b9cc72d70391936ff5e698f28 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-03 | 164 | 19 | 2 | 7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6 | |
| ToppCell | Ionocyte|World / shred by cell class for turbinate | 2.19e-03 | 165 | 19 | 2 | 0cb2199b87f17ece743fb2652b2f448dfa78ae0b | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.19e-03 | 165 | 19 | 2 | 8329d780f244bc31344443b29e5a00529a016662 | |
| ToppCell | droplet-Fat-Scat-21m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-03 | 165 | 19 | 2 | 3f0c2486ea357d10dad0b703cf75cc29bdd5b5cf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-03 | 165 | 19 | 2 | dc570154baed59ed109e5369589448e075ba66a9 | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.19e-03 | 165 | 19 | 2 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.19e-03 | 165 | 19 | 2 | 6799a6580c667738995cceb31cbf1c7fbdc4ff84 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.19e-03 | 165 | 19 | 2 | 9e2fa634f4749e35aa5dca43476477b5d362afd7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_TNFAIP8L3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.19e-03 | 165 | 19 | 2 | cd73bba51f3f4871533c3512bdc0a1f05716344b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.22e-03 | 166 | 19 | 2 | 4547d997afc43e647b1a08e70d5c7fff0e42048f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.22e-03 | 166 | 19 | 2 | afba41e15478053f11815acf568d29187de75492 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.22e-03 | 166 | 19 | 2 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.25e-03 | 167 | 19 | 2 | 26cd8ee5e826e71eaf58d10a906543a6932fb3f9 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.25e-03 | 167 | 19 | 2 | b93103a868fba63a8910bffb690a6242b9252833 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.25e-03 | 167 | 19 | 2 | fcd583b1efd0ac883379982ea8e6c54f2c0be268 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.25e-03 | 167 | 19 | 2 | f6bc63138b7239211fa5f27a8dc799b6e022c0f8 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.25e-03 | 167 | 19 | 2 | ded4d6cccd3660662f12cf5a512de31d26325f1b | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.27e-03 | 168 | 19 | 2 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.30e-03 | 169 | 19 | 2 | f077e39e41fffe7672541f5b72b80faaf56c597c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.30e-03 | 169 | 19 | 2 | f47c4fbdc2a38745ec1b35104b85121c1413875a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.30e-03 | 169 | 19 | 2 | 876e666220a4041826dac313082fdd44da15b2b1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.33e-03 | 170 | 19 | 2 | 667443062882642211ad116043775ef8eda38859 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-03 | 170 | 19 | 2 | 35e3945d8a540a3e2cec1b559316265aaad023d1 | |
| ToppCell | CV-Mild-7|CV / Virus stimulation, Condition and Cluster | 2.33e-03 | 170 | 19 | 2 | 25ebde7d2f8ae1afdfaf5876284ff20bb179eb10 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-03 | 170 | 19 | 2 | 0ea625abaa25bab93b70b7000e8f90d5c0f9a0fb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_RCN1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.33e-03 | 170 | 19 | 2 | 17b8c53c69d78d1b343a5f86d4f82896deee1b0d | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte2_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.33e-03 | 170 | 19 | 2 | 3886a77bc3ddbeb42a8149b759fe578871676d6e | |
| Drug | EPTC | 3.17e-06 | 35 | 19 | 3 | CID000012968 | |
| Drug | Cortisporin | 1.25e-05 | 177 | 19 | 4 | CID000004454 | |
| Drug | Dns-C6-Cho | 3.61e-05 | 11 | 19 | 2 | CID000124728 | |
| Drug | dihydronereistoxin | 3.61e-05 | 11 | 19 | 2 | CID000121232 | |
| Drug | AC1L9NC9 | 3.61e-05 | 11 | 19 | 2 | CID000449642 | |
| Drug | bipinnatin-B | 3.61e-05 | 11 | 19 | 2 | CID000127363 | |
| Drug | LJP 1082 | 3.61e-05 | 11 | 19 | 2 | CID003037609 | |
| Drug | SureCN373116 | 4.33e-05 | 12 | 19 | 2 | CID010085732 | |
| Drug | AC1L9P8C | 4.33e-05 | 12 | 19 | 2 | CID000450864 | |
| Drug | ethidium bromide | 4.66e-05 | 85 | 19 | 3 | CID000003624 | |
| Drug | AC1L9KC8 | 5.12e-05 | 13 | 19 | 2 | CID000446992 | |
| Drug | C-toxiferine-I | 5.12e-05 | 13 | 19 | 2 | CID005089093 | |
| Drug | nereistoxin | 5.12e-05 | 13 | 19 | 2 | CID000015401 | |
| Drug | bipinnatin-C | 5.12e-05 | 13 | 19 | 2 | CID000129977 | |
| Drug | 1-acetyl-4-methylpiperazine methiodide | 5.12e-05 | 13 | 19 | 2 | CID004392675 | |
| Drug | bipinnatin-A | 5.12e-05 | 13 | 19 | 2 | CID000196603 | |
| Drug | 2,3-dichlorooctafluorobutane | 5.97e-05 | 14 | 19 | 2 | CID000078982 | |
| Drug | LNF 209 | 5.97e-05 | 14 | 19 | 2 | CID000132666 | |
| Drug | aa373 | 6.88e-05 | 15 | 19 | 2 | CID000191672 | |
| Drug | (-)-pictamine | 6.88e-05 | 15 | 19 | 2 | CID006918623 | |
| Drug | (-)-lepadin B | 6.88e-05 | 15 | 19 | 2 | CID006918624 | |
| Drug | AC1L4Q08 | 6.88e-05 | 15 | 19 | 2 | CID000161747 | |
| Drug | N-methylcytisine | 6.88e-05 | 15 | 19 | 2 | CID000234566 | |
| Drug | SAD-128 | 6.88e-05 | 15 | 19 | 2 | CID000162008 | |
| Drug | anatoxin-a hydrochloride | 6.88e-05 | 15 | 19 | 2 | CID000135265 | |
| Drug | UB-165 | 6.88e-05 | 15 | 19 | 2 | CID004694339 | |
| Drug | ivermectin | 7.80e-05 | 101 | 19 | 3 | CID006435110 | |
| Drug | AC1L2SVN | 7.86e-05 | 16 | 19 | 2 | CID000127922 | |
| Drug | benzoquinonium | 7.86e-05 | 16 | 19 | 2 | CID000009393 | |
| Drug | 3-(trifluoromethyl)-3-(m-iodophenyl)diazirine | 7.86e-05 | 16 | 19 | 2 | CID000123866 | |
| Drug | PNU-282,987 | 7.86e-05 | 16 | 19 | 2 | CID004655349 | |
| Drug | Nsc36388 | 8.91e-05 | 17 | 19 | 2 | CID000014954 | |
| Drug | oxotremorine | 9.52e-05 | 108 | 19 | 3 | CID000004630 | |
| Drug | ABT-594 | 1.00e-04 | 18 | 19 | 2 | CID003075702 | |
| Drug | AC1O8PVM | 1.00e-04 | 18 | 19 | 2 | CID000004989 | |
| Drug | AC1LCVGE | 1.00e-04 | 18 | 19 | 2 | CID000656712 | |
| Drug | benzetimide | 1.00e-04 | 18 | 19 | 2 | CID000021846 | |
| Drug | isoarecolone | 1.12e-04 | 19 | 19 | 2 | CID000146970 | |
| Drug | beta-erythroidine | 1.12e-04 | 19 | 19 | 2 | CID000010074 | |
| Drug | perhydrohistrionicotoxin | 1.12e-04 | 19 | 19 | 2 | CID000107881 | |
| Drug | PNU-120596 | 1.12e-04 | 19 | 19 | 2 | CID000311434 | |
| Drug | AC1L9P88 | 1.12e-04 | 19 | 19 | 2 | CID000450860 | |
| Drug | 4-(N-maleimido)benzyltrimethylammonium | 1.12e-04 | 19 | 19 | 2 | CID000162425 | |
| Drug | AC1Q5X7V | 1.24e-04 | 20 | 19 | 2 | CID000050190 | |
| Drug | 3-(2-azetidinylmethoxy)pyridine | 1.24e-04 | 20 | 19 | 2 | CID000001962 | |
| Drug | Dichloride, Alcuronium | 1.24e-04 | 20 | 19 | 2 | CID003032788 | |
| Drug | meproadifen | 1.37e-04 | 21 | 19 | 2 | CID000189752 | |
| Drug | dinotefuran | 1.37e-04 | 21 | 19 | 2 | CID000197701 | |
| Drug | suberyldicholine | 1.51e-04 | 22 | 19 | 2 | CID000123989 | |
| Drug | clothianidin | 1.51e-04 | 22 | 19 | 2 | CID000213027 | |
| Drug | AR-R17779 | 1.51e-04 | 22 | 19 | 2 | CID005310971 | |
| Drug | histrionicotoxin | 1.51e-04 | 22 | 19 | 2 | CID005282247 | |
| Drug | AC1L3BL8 | 1.65e-04 | 23 | 19 | 2 | CID000086457 | |
| Drug | ABT-418 | 1.65e-04 | 23 | 19 | 2 | CID000119380 | |
| Drug | alpha-conotoxin SI | 1.65e-04 | 23 | 19 | 2 | CID000163979 | |
| Drug | Skpymrfamide | 1.65e-04 | 23 | 19 | 2 | CID000132661 | |
| Drug | alpha-conotoxin ImI | 1.65e-04 | 23 | 19 | 2 | CID000133011 | |
| Drug | CID6325740 | 1.65e-04 | 23 | 19 | 2 | CID006325740 | |
| Drug | procyclidine | 1.80e-04 | 24 | 19 | 2 | CID000004919 | |
| Drug | intruder | 1.80e-04 | 24 | 19 | 2 | CID000213021 | |
| Drug | anabaseine | 1.80e-04 | 24 | 19 | 2 | CID000018985 | |
| Drug | AC1L2IZE | 1.80e-04 | 24 | 19 | 2 | CID000072928 | |
| Drug | varenicline | 1.96e-04 | 25 | 19 | 2 | CID000170361 | |
| Drug | anabasine | 1.96e-04 | 25 | 19 | 2 | CID000002181 | |
| Drug | PrBCM | 1.96e-04 | 25 | 19 | 2 | CID000037396 | |
| Drug | pempidine | 1.96e-04 | 25 | 19 | 2 | CID000006603 | |
| Drug | benzquinamide | 2.12e-04 | 26 | 19 | 2 | CID000002342 | |
| Drug | beta-eudesmol | 2.12e-04 | 26 | 19 | 2 | CID000091457 | |
| Drug | curarine | 2.12e-04 | 26 | 19 | 2 | CID000198004 | |
| Drug | imidazolidine | 2.12e-04 | 26 | 19 | 2 | CID000449488 | |
| Drug | m(7)GpppG | 2.18e-04 | 143 | 19 | 3 | CID000121958 | |
| Drug | nicardipine | 2.27e-04 | 145 | 19 | 3 | CID000004473 | |
| Drug | methylcarbamylcholine | 2.29e-04 | 27 | 19 | 2 | CID000004136 | |
| Drug | nornicotine | 2.29e-04 | 27 | 19 | 2 | CID000000412 | |
| Drug | pentolinium | 2.46e-04 | 28 | 19 | 2 | CID000005849 | |
| Drug | echothiophate | 2.46e-04 | 28 | 19 | 2 | CID000010547 | |
| Drug | bifemelane | 2.64e-04 | 29 | 19 | 2 | CID000002377 | |
| Drug | bromoacetylcholine bromide | 2.64e-04 | 29 | 19 | 2 | CID000204966 | |
| Drug | (2S,3R)-Sphingosine | 2.65e-04 | 389 | 19 | 4 | CID000001104 | |
| Drug | procaine | 2.66e-04 | 153 | 19 | 3 | CID000004914 | |
| Drug | methylenedioxydimethylamphetamine | 2.83e-04 | 30 | 19 | 2 | CID000551630 | |
| Drug | vecuronium | 2.83e-04 | 30 | 19 | 2 | CID000039764 | |
| Drug | AC1L1JK6 | 3.02e-04 | 31 | 19 | 2 | CID000005077 | |
| Drug | tetrahydrodeoxycortisol | 3.02e-04 | 31 | 19 | 2 | CID000010593 | |
| Drug | quinuclidine | 3.02e-04 | 31 | 19 | 2 | CID000007527 | |
| Drug | M3/M4 | 3.22e-04 | 32 | 19 | 2 | CID000486507 | |
| Drug | tropicamide | 3.22e-04 | 32 | 19 | 2 | CID000005593 | |
| Drug | decamethonium | 3.43e-04 | 33 | 19 | 2 | CID000002968 | |
| Drug | methamidophos | 3.43e-04 | 33 | 19 | 2 | CID000004096 | |
| Drug | cytisine | 3.43e-04 | 33 | 19 | 2 | CID000010235 | |
| Drug | GTS-21 | 3.64e-04 | 34 | 19 | 2 | CID005310985 | |
| Drug | thiacloprid | 3.64e-04 | 34 | 19 | 2 | CID000115224 | |
| Drug | l-Lobeline | 3.64e-04 | 34 | 19 | 2 | CID000003945 | |
| Drug | atracurium | 3.86e-04 | 35 | 19 | 2 | CID000047319 | |
| Drug | gallamine | 3.86e-04 | 35 | 19 | 2 | CID000003450 | |
| Drug | (+/-)-Epibatidine | 3.86e-04 | 35 | 19 | 2 | CID000001204 | |
| Drug | PhTX-343 | 4.09e-04 | 36 | 19 | 2 | CID000159548 | |
| Drug | LS-63783 | 4.17e-04 | 804 | 19 | 5 | CID000000231 | |
| Drug | vitamin E | 4.27e-04 | 441 | 19 | 4 | CID000002116 | |
| Drug | HHSiD | 4.32e-04 | 37 | 19 | 2 | CID000003602 | |
| Disease | cognitive disorder (implicated_via_orthology) | 5.26e-06 | 6 | 18 | 2 | DOID:1561 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis (biomarker_via_orthology) | 5.26e-06 | 6 | 18 | 2 | DOID:7148 (biomarker_via_orthology) | |
| Disease | nicotine dependence (implicated_via_orthology) | 2.31e-05 | 12 | 18 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | lymphoid leukemia | 2.44e-04 | 38 | 18 | 2 | EFO_0004289 | |
| Disease | irritable bowel syndrome symptom measurement | 5.69e-04 | 58 | 18 | 2 | EFO_0021536 | |
| Disease | schizophrenia (implicated_via_orthology) | 7.82e-04 | 68 | 18 | 2 | DOID:5419 (implicated_via_orthology) | |
| Disease | orofacial cleft, sex interaction measurement | 1.25e-03 | 86 | 18 | 2 | EFO_0008343, MONDO_0000358 | |
| Disease | gastroesophageal reflux disease | 1.71e-03 | 101 | 18 | 2 | EFO_0003948 | |
| Disease | Schizophrenia | 1.74e-03 | 883 | 18 | 4 | C0036341 | |
| Disease | Neoplasm Invasiveness | 5.54e-03 | 184 | 18 | 2 | C0027626 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 6.51e-03 | 200 | 18 | 2 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | Seizures | 7.69e-03 | 218 | 18 | 2 | C0036572 | |
| Disease | Lung Neoplasms | 1.12e-02 | 265 | 18 | 2 | C0024121 | |
| Disease | Malignant neoplasm of lung | 1.13e-02 | 266 | 18 | 2 | C0242379 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ANEDPEHPHANHGRF | 261 | Q6ZTR7 | |
| PHQRGESHHPPEFQD | 51 | Q8NEC5 | |
| LQEEGAFGHDPHLHG | 401 | Q86SQ6 | |
| GPHPHGHEAEGSQDY | 146 | Q99767 | |
| HDEHLLHGGQPPEGD | 416 | P36544 | |
| EPGGSDQEHSPHHQC | 966 | Q96JA1 | |
| HDEHLLHGGQPPEGD | 326 | Q494W8 | |
| PFIGEDDNDDGHPLH | 21 | Q6MZM9 | |
| GPPQQHGHHNEFDDE | 516 | Q5T0N5 | |
| GNPGDHHDFEPQRHD | 621 | O75912 | |
| GHPGEHHDFEPQRHD | 541 | Q13574 | |
| NGHDPGRGHQDLDPD | 286 | Q9ULF5 | |
| PGGTHPEDHQGHSDQ | 311 | Q9BYZ6 | |
| EGQHYPERHGGPERH | 776 | Q15424 | |
| NGPEHQPNGETHESH | 846 | Q9UQC9 | |
| VDGNHFQHPAGDCHP | 101 | Q8N812 | |
| RHVHHQDQGPDSFPD | 86 | Q16281 | |
| LSEPGNQAPDHEHGH | 121 | Q96LW9 | |
| DGGPHRIDHQEHPRD | 346 | Q9BXU3 |